Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Birgit Røge"'
Autor:
Ole S Søgaard, Nicolai Lohse, Lars Østergaard, Gitte Kronborg, Birgit Røge, Jan Gerstoft, Henrik T Sørensen, Niels Obel
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e32538 (2012)
BACKGROUND: Early identification of persons with undiagnosed HIV infection is an important health care issue. We examined associations between diseases diagnosed in hospitals and risk of subsequent HIV diagnosis. METHODS: In this population-based cas
Externí odkaz:
https://doaj.org/article/6813fe155cd449299d331a2835d83404
Autor:
Nina Weis, Anders Gorm Pedersen, Jens Bukh, Peter Thielsen, Kristian Schønning, Ulrik Fahnøe, Martin Schou Pedersen, Alex Lund Laursen, Christina Sølund, Jan Gerstoft, Peer Brehm Christensen, Birgit Røge, Anja Ernst, Henrik Krarup, Lone Galmstrup Madsen
Publikováno v:
Fahnøe, U, Pedersen, M S, Sølund, C, Ernst, A, Krarup, H B, Røge, B T, Christensen, P B, Laursen, A L, Gerstoft, J, Thielsen, P, Madsen, L G, Pedersen, A G, Schønning, K, Weis, N & Bukh, J 2021, ' Global evolutionary analysis of chronic hepatitis C patients revealed significant effect of baseline viral resistance, including novel non-target sites, for DAA-based treatment and retreatment outcome ', Journal of Viral Hepatitis, vol. 28, no. 2, pp. 302-316 . https://doi.org/10.1111/jvh.13430
Direct-acting antivirals (DAAs) have proven highly effective against chronic hepatitis C virus (HCV) infection. However, some patients experience treatment failure, associated with resistance-associated substitutions (RASs). Our aim was to investigat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4b2a455c59278d960b28947235500c5
https://doi.org/10.1111/jvh.13430
https://doi.org/10.1111/jvh.13430
Autor:
Birgit Røge, Belinda Klemmensen Mössner, Jacob Søholm, Nina Weis, Janne Fuglsang Hansen, Toke S Barfod, Suzanne Lunding, Peer Brehm Christensen, Jesper Bach Hansen, Anne Øvrehus, Alex Lauersen, Peter Thielsen, Rajesh Mohey
Publikováno v:
Søholm, J, Hansen, J F, Mössner, B, Røge, B T, Lauersen, A, Hansen, J B, Weis, N, Barfod, T S, Lunding, S, Øvrehus, A, Mohey, R, Thielsen, P & Christensen, P B 2020, ' Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs ', PLoS ONE, vol. 15, no. 12 December, e0243725 . https://doi.org/10.1371/journal.pone.0243725
PLoS ONE, Vol 15, Iss 12, p e0243725 (2020)
Søholm, J, Hansen, J F, Mössner, B, Røge, B T, Lauersen, A, Hansen, J B, Weis, N, Barfod, T S, Lunding, S, Øvrehus, A, Mohey, R, Thielsen, P & Christensen, P B 2020, ' Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs ', PLOS ONE, vol. 15, no. 12, e0243725 . https://doi.org/10.1371/journal.pone.0243725
PLoS ONE
Søholm, J, Hansen, J F, Mössner, B, Røge, B T, Lauersen, A, Hansen, J B, Weis, N, Barfod, T S, Lunding, S, Øvrehus, A, Mohey, R, Thielsen, P & Christensen, P B 2020, ' Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs ', PLOS ONE, vol. 15, no. 12 December, e0243725 . https://doi.org/10.1371/journal.pone.0243725
PLoS ONE, Vol 15, Iss 12, p e0243725 (2020)
Søholm, J, Hansen, J F, Mössner, B, Røge, B T, Lauersen, A, Hansen, J B, Weis, N, Barfod, T S, Lunding, S, Øvrehus, A, Mohey, R, Thielsen, P & Christensen, P B 2020, ' Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs ', PLOS ONE, vol. 15, no. 12, e0243725 . https://doi.org/10.1371/journal.pone.0243725
PLoS ONE
Søholm, J, Hansen, J F, Mössner, B, Røge, B T, Lauersen, A, Hansen, J B, Weis, N, Barfod, T S, Lunding, S, Øvrehus, A, Mohey, R, Thielsen, P & Christensen, P B 2020, ' Low incidence of HCC in chronic hepatitis C patients with pretreatment liver stiffness measurements below 17.5 kilopascal who achieve SVR following DAAs ', PLOS ONE, vol. 15, no. 12 December, e0243725 . https://doi.org/10.1371/journal.pone.0243725
Background and aims To evaluate the ability of pretreatment liver stiffness measurements (pLSM) to predict hepatocellular carcinoma (HCC), incident decompensation and all-cause mortality in chronic hepatitis C (CHC) patients who achieved sustained vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3db6e10954a8a03aa77c1566fb4a23c
https://curis.ku.dk/portal/da/publications/low-incidence-of-hcc-in-chronic-hepatitis-c-patients-with-pretreatment-liver-stiffness-measurements-below-175-kilopascal-who-achieve-svr-following-daas(943ef18d-b7dd-4a4e-a3c0-60c5cbc9b14f).html
https://curis.ku.dk/portal/da/publications/low-incidence-of-hcc-in-chronic-hepatitis-c-patients-with-pretreatment-liver-stiffness-measurements-below-175-kilopascal-who-achieve-svr-following-daas(943ef18d-b7dd-4a4e-a3c0-60c5cbc9b14f).html
Autor:
Erika Belard, Lone Galmstrup Madsen, Mette S Kjær, Geir Noraberg, Ola Weiland, Nina Weis, Henrik Krarup, Alex Lund Laursen, Lars Normann Karlsen, Ulla Balslev, Olav Dalgard, Anne Øvrehus, Sofie Hallager, Martin Lagging, Lars Heggelund, Martti Färkkilâ, Birgit Røge
Publikováno v:
Dalgard, O, Weiland, O, Noraberg, G, Karlsen, L, Heggelund, L, Färkkilâ, M, Balslev, U, Belard, E, Øvrehus, A, Skalshøi Kjær, M, Krarup, H, Thorup Røge, B, Hallager, S, Madsen, L G, Lund Laursen, A, Lagging, M & Weis, N 2017, ' Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections : A Scandinavian real-life study ', PLOS ONE, vol. 12, no. 7, e0179764 . https://doi.org/10.1371/journal.pone.0179764
PLoS ONE, Vol 12, Iss 7, p e0179764 (2017)
Dalgard, O, Weiland, O, Noraberg, G, Karlsen, L, Heggelund, L, Färkkilâ, M, Balslev, U, Belard, E, Øvrehus, A, Skalshøi Kjær, M, Krarup, H, Thorup Røge, B, Hallager, S, Madsen, L G, Lund Laursen, A, Lagging, M & Weis, N 2017, ' Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study ', PloS one, vol. 12, no. 7, e0179764 . https://doi.org/10.1371/journal.pone.0179764
Dalgard, O, Weiland, O, Noraberg, G, Karlsen, L, Heggelund, L, Färkkilâ, M, Balslev, U, Belard, E, Øvrehus, A, Skalshøi Kjær, M, Krarup, H, Thorup Røge, B, Hallager, S, Madsen, L G, Lund Laursen, A, Lagging, M & Weis, N 2017, ' Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study ', P L o S One, vol. 12, no. 7, pp. e0179764 . https://doi.org/10.1371/journal.pone.0179764
PLoS ONE
PLoS ONE, Vol 12, Iss 7, p e0179764 (2017)
Dalgard, O, Weiland, O, Noraberg, G, Karlsen, L, Heggelund, L, Färkkilâ, M, Balslev, U, Belard, E, Øvrehus, A, Skalshøi Kjær, M, Krarup, H, Thorup Røge, B, Hallager, S, Madsen, L G, Lund Laursen, A, Lagging, M & Weis, N 2017, ' Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study ', PloS one, vol. 12, no. 7, e0179764 . https://doi.org/10.1371/journal.pone.0179764
Dalgard, O, Weiland, O, Noraberg, G, Karlsen, L, Heggelund, L, Färkkilâ, M, Balslev, U, Belard, E, Øvrehus, A, Skalshøi Kjær, M, Krarup, H, Thorup Røge, B, Hallager, S, Madsen, L G, Lund Laursen, A, Lagging, M & Weis, N 2017, ' Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study ', P L o S One, vol. 12, no. 7, pp. e0179764 . https://doi.org/10.1371/journal.pone.0179764
PLoS ONE
BACKGROUND AND AIMS: Chronic hepatitis C virus (HCV) genotype 3 infection with advanced liver disease has emerged as the most challenging to treat. We retrospectively assessed the treatment outcome of sofosbuvir (SOF) based regimes for treatment of H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d34309f14de034eaa686df7c02d7cf19
https://hdl.handle.net/10642/7274
https://hdl.handle.net/10642/7274
Autor:
Steen Ladelund, Lone Galmstrup Madsen, Sofie Hallager, Nina Weis, Mette S Kjær, Henrik Krarup, Alex Lund Laursen, Karin Elmegaard Grønbæk, Jan Gerstoft, Erika Belard, Peer Brehm Christensen, Birgit Røge
Publikováno v:
Hallager, S, Ladelund, S, S. Kjaer, M, Madsen, L G, Belard, E, Laursen, A L, Gerstoft, J, Røge, B T, Grønbæk, K E, Krarup, H B, Christensen, P B & Weis, N 2018, ' Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark : a nationwide cohort study ', Journal of Viral Hepatitis, vol. 25, no. 1, pp. 47-55 . https://doi.org/10.1111/jvh.12764
Hallager, S, Ladelund, S, Kjaer, M S, Madsen, L G, Belard, E, Laursen, A L, Gerstoft, J, Røge, B T, Elmegaard Grønbæk, K, Krarup, H B, Christensen, P B & Weis, N 2018, ' Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark : a nationwide cohort study ', Journal of Viral Hepatitis, vol. 25, no. 1, pp. 47–55 . https://doi.org/10.1111/jvh.12764
Hallager, S, Ladelund, S, Kjaer, M S, Madsen, L G, Belard, E, Laursen, A L, Gerstoft, J, Røge, B T, Grønbaek, K E, Krarup, H B, Christensen, P B & Weis, N 2018, ' Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark : a nationwide cohort study ', Journal of Viral Hepatitis . https://doi.org/10.1111/jvh.12764
Hallager, S, Ladelund, S, Kjaer, M S, Madsen, L G, Belard, E, Laursen, A L, Gerstoft, J, Røge, B T, Elmegaard Grønbæk, K, Krarup, H B, Christensen, P B & Weis, N 2018, ' Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark : a nationwide cohort study ', Journal of Viral Hepatitis, vol. 25, no. 1, pp. 47–55 . https://doi.org/10.1111/jvh.12764
Hallager, S, Ladelund, S, Kjaer, M S, Madsen, L G, Belard, E, Laursen, A L, Gerstoft, J, Røge, B T, Grønbaek, K E, Krarup, H B, Christensen, P B & Weis, N 2018, ' Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark : a nationwide cohort study ', Journal of Viral Hepatitis . https://doi.org/10.1111/jvh.12764
Cirrhosis in patients with chronic hepatitis C increases the risk of hepatocellular carcinoma (HCC) and surveillance with ultrasound (US) and alpha-fetoprotein (AFP) is recommended. This study aimed to estimate changes in the HCC incidence rate (IR)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c39aa5d178642933c8f99d439346069c
https://pubmed.ncbi.nlm.nih.gov/28750141
https://pubmed.ncbi.nlm.nih.gov/28750141
Autor:
Birgit Røge, Jan Gerstoft, Frederik Neess Engsig, Gitte Kronborg, Tavs Qvist, Carsten Schade Larsen, Niels Obel
Publikováno v:
Qvist, T, Engsig, F N, Kronborg, G, Larsen, C S, Røge, B, Gerstoft, J & Obel, N 2010, ' Predictors of unsafe sex among HIV patients in Denmark: A population-based cohort study ', Scandinavian Journal of Infectious Diseases . https://doi.org/10.3109/00365548.2010.534501
Qvist, T, Engsig, F N, Kronborg, G, Larsen, C S, Røge, B, Gerstoft, J & Obel, N 2011, ' Predictors of unsafe sex among HIV patients in Denmark: A population-based cohort study ', Scandinavian Journal of Infectious Diseases, vol. 43, no. 3, pp. 181-187 . https://doi.org/10.3109/00365548.2010.534501
Qvist, T, Engsig, F N, Kronborg, G, Larsen, C S, Røge, B, Gerstoft, J & Obel, N 2011, ' Predictors of unsafe sex among HIV patients in Denmark: A population-based cohort study ', Scandinavian Journal of Infectious Diseases, vol. 43, no. 3, pp. 181-187 . https://doi.org/10.3109/00365548.2010.534501
Background: Sexual transmission continues to be the primary mode of human immunodeficiency virus (HIV) infection in Western Europe. We aimed to describe predictors of unsafe sex and reasons given for such behaviour. Methods: We performed a survey exa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8c06051e73bc60c7eaea3f11425ed65
https://doi.org/10.3109/00365548.2010.534501
https://doi.org/10.3109/00365548.2010.534501
Autor:
Gitte Kronborg, Niels Obel, Carsten Schade Larsen, Gitte Pedersen, Mette Vang Larsen, Lars Haukali Omland, Jan Gerstoft, Birgit Røge
Publikováno v:
Larsen, M V, Omland, L H H, Gerstoft, J, Røge, B T, Larsen, C S, Pedersen, G, Obel, N & Kronborg, G 2010, ' Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study ', Scandinavian Journal of Infectious Diseases, vol. 42, no. 11-12, pp. 917-23 . https://doi.org/10.3109/00365548.2010.511258
Larsen, M V, Omland, L H, Gerstoft, J, Røge, B T, Larsen, C S, Pedersen, G, Obel, N & Kronborg, G 2010, ' Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: A nationwide population-based cohort study ', Scandinavian Journal of Infectious Diseases, vol. 42, no. 11-12, pp. 917-23 . https://doi.org/10.3109/00365548.2010.511258
Larsen, M V, Omland, L H, Gerstoft, J, Røge, B T, Larsen, C S, Pedersen, G, Obel, N & Kronborg, G 2010, ' Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: A nationwide population-based cohort study ', Scandinavian Journal of Infectious Diseases, vol. 42, no. 11-12, pp. 917-23 . https://doi.org/10.3109/00365548.2010.511258
Udgivelsesdato: 2010-Dec Abstract The objective of this study was to determine the effect of highly active antiretroviral therapy (HAART) in human immunodeficiency virus (HIV)-infected patients infected through injecting drug use (injecting drug user
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7d3f20215604c9e8631efb14ff659ca
https://doi.org/10.3109/00365548.2010.511258
https://doi.org/10.3109/00365548.2010.511258
Autor:
Birgit Røge, Terese L. Katzenstein, T Barrington, Jan Gerstoft, J Wandall, Peter Skinhøj, Henrik Ullum, Ebbe Dickmeiss
Publikováno v:
University of Southern Denmark
University of Copenhagen
Katzenstein, T, Ullum, H, Røge, B T, Wandall, J, Dickmeiss, E, Barington, T, Skinhøj, P & Gerstoft, J 2003, ' Virological and immunological profiles among patients with undetectable viral load followed prospectively for 24 months ', HIV Medicine, vol. 4, pp. 53-61 .
University of Copenhagen
Katzenstein, T, Ullum, H, Røge, B T, Wandall, J, Dickmeiss, E, Barington, T, Skinhøj, P & Gerstoft, J 2003, ' Virological and immunological profiles among patients with undetectable viral load followed prospectively for 24 months ', HIV Medicine, vol. 4, pp. 53-61 .
To quantify HIV-RNA in plasma, in lymphoid tissue and proviral DNA in peripheral blood mononuclear cells and to relate these to immunological markers among patients with plasma viral load counts of/= 200 HIV-RNA copies/mL.A prospective study of one h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99fb8772144dfd2d086407aa42e3eae8
https://doi.org/10.1046/j.1468-1293.2003.00119.x
https://doi.org/10.1046/j.1468-1293.2003.00119.x
Publikováno v:
HIV Medicine. 4:38-47
Objectives To determine resistance mutations emerging in HIV-1-infected patients experiencing their first protease inhibitor (PI)-failure on nelfinavir-containing highly active antiretroviral therapy (HAART), and to assess virological response to res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14a53bcfdc27a49af10a2ea83aaf1505
https://doi.org/10.1046/j.1468-1293.2003.00133.x
https://doi.org/10.1046/j.1468-1293.2003.00133.x
Publikováno v:
Experimental Gerontology. 37:693-699
Low-grade inflammatory activity is strongly associated with age-associated diseases such as atherosclerosis, dementia, type-2 diabetes, sarcopenia, and osteoporosis and predicts mortality risk in elderly populations. The aim of the current study was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60bc2f56e5aa782d881d2b03fd0faeff
https://doi.org/10.1016/s0531-5565(02)00002-5
https://doi.org/10.1016/s0531-5565(02)00002-5